(Q36843031)

16 August 2017

Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out. (English)

1 reference

16 August 2017

0 references

1 reference

4

Yuqing Zhang

1 reference

16 August 2017

2

Frederick Wolfe

1 reference

16 August 2017

Jingbo Niu

3

0 references

Michael LaValley

object named as

Michael LaValley

series ordinal

6

0 references

author name string

Saralynn Allaire

series ordinal

1

1 reference

PMC publication ID

3653626

16 August 2017

Bin Zhang

series ordinal

5

1 reference

16 August 2017

1 August 2008

1 reference

16 August 2017

Arthritis & Rheumatology

1 reference

16 August 2017

59

1 reference

16 August 2017

8

1 reference

16 August 2017

1082-1089

1 reference

Trials in rheumatoid arthritis: choosing the right outcome measure when minimal disease is achievable

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmö, Sweden

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Readers should systematically assess methods used to identify, measure and analyze confounding in observational cohort studies.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Pharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

The impact of new biologicals in the treatment of rheumatoid arthritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Update on work disability in rheumatic diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

The costs of rheumatoid arthritis: an international long-term view

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Predictors of work disability in rheumatoid arthritis patients. A five-year followup

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Empiric comparison of multivariate analytic techniques: advantages and disadvantages of recursive partitioning analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Statistical approaches to classification. Methods for developing classification and other criteria rules.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Association between etanercept use and employment outcomes among patients with rheumatoid arthritis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

Delay in imaging versus clinical response: A rationale for prolonged treatment with anti–tumor necrosis factor medication in early rheumatoid arthritis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653626

The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales

4 December 2018

1 reference

12 December 2020

Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis

1 reference

12 December 2020

Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project)

1 reference

12 December 2020

Infliximab treatment maintains employability in patients with early rheumatoid arthritis

1 reference

12 December 2020

Community-based evaluation of etanercept in patients with rheumatoid arthritis

1 reference

12 December 2020

Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time

1 reference

12 December 2020

Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis

1 reference

12 December 2020

The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability

1 reference

12 December 2020

Effect of anti-tumor necrosis factor on work disability

1 reference

12 December 2020

Identifiers

DOI

10.1002/ART.23923

1 reference

16 August 2017

1 reference

PMC publication ID

3653626

16 August 2017

PubMed publication ID

18668597

1 reference

PMC publication ID

3653626